Outcomes in Treatment of Rhinosinusitis in the Setting of Medication Induced Immunosuppression.
Rahul AlapatiJayakar V NayakPeter H HwangZara M PatelPublished in: American journal of rhinology & allergy (2020)
Patients experiencing chronic rhinosinusitis and recurrent acute rhinosinusitis who are taking immunosuppressive medication can significantly improve from both medical and surgical management, but upfront surgical management appears to result in greater disease resolution relative to medical management in those with CRS. More study is needed in the RARS patient population regarding upfront surgery versus medical management.
Keyphrases
- healthcare
- end stage renal disease
- chronic rhinosinusitis
- newly diagnosed
- chronic kidney disease
- ejection fraction
- minimally invasive
- drug induced
- liver failure
- peritoneal dialysis
- prognostic factors
- adverse drug
- type diabetes
- high glucose
- emergency department
- oxidative stress
- coronary artery bypass
- case report
- respiratory failure
- intensive care unit
- diabetic rats
- metabolic syndrome
- adipose tissue
- endothelial cells
- acute coronary syndrome
- patient reported
- surgical site infection
- electronic health record